Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05609240Phase 2Recruiting
A Phase 2 trial of cefuroxime in surgical site infection (SSI), urinary tract infection (UTI), pneumonia, pyelonephritis, sponsored by University of Leeds. Started May 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05609240.